Last $12.60 USD
Change Today -0.25 / -1.95%
Volume 1.7M
IRWD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stanley Falkow Ph.D.

Scientific Advisor, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 48 board members in 3 different organizations across 8 different industries.

See Board Relationships
----

Background*

Dr. Stanley Falkow, PhD serves as Scientific Advisor of Ironwood Pharmaceuticals Inc. (formerly, Microbia Inc.). Dr. Falkow served as Chairman of the Department of Medical Microbiology at Stanford University from 1981 to 1985. He serves as a Member of Scientific Advisory Board at AvidBiotics Corp. He serves on the Scientific Advisory Board of Protein Design Labs. He serves as a Member of Scientific Advisory Board of Functional Genetics, Inc. and as a Member of Advisory ...

Read Full Background

Corporate Headquarters*

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
The Leland Stanford Junior University
PhD
Brown University
BS
University of Maine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRWD:US $12.60 USD -0.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance, Treasurer and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRONWOOD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.